Sample size calculation for a hypothesis test

JAMA

Volumn 312, Issue 2, 2014, Pages 180-181

  Stokes, Lynne ^a  

^a SOUTHERN METHODIST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE PATCH; VARENICLINE;

AGE; CALCULATION; DECISION MAKING; HUMAN; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MINIMUM DETECTABLE DIFFERENCE; OUTCOME ASSESSMENT; POWER ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY SAMPLE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SAMPLE SIZE; SAMPLING ERROR; SCIENTIST; SMOKING CESSATION; STATISTICAL PARAMETERS;

BIOMEDICAL RESEARCH; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE;

EID: 84903883714     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.8295     Document Type: Review

References (4)

1. Koegelenberg CFN, Noor F, Bateman ED, et al. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.7195.
2. Hajek P, Smith KM, Dhanji AR, McRobbie H. Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? a randomised controlled trial. BMC Med. 2013;11:140.
3. Ebbert JO, Burke MV, Hays JT, Hurt RD. Combination treatment with varenicline and nicotine replacement therapy. Nicotine Tob Res. 2009;11(5):572-576.
4. Besada NA, Guerrero AC, Fernandez MI, Ulibarri MM, Jiménez-Ruiz CA. Clinical experience from a smokers clinic combining varenicline and nicotine gum. Eur Respir J. 2010;36(suppl 54):462s.